MetLife Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-242,594
| Closed | -$215K | – | 2849 |
|
|
2022
Q4 | $215K | Buy |
242,594
+43,714
| +22% | +$38.7K | ﹤0.01% | 2205 |
|
|
2022
Q3 | $312K | Hold |
198,880
| – | – | ﹤0.01% | 1990 |
|
|
2022
Q2 | $400K | Buy |
198,880
+80,929
| +69% | +$163K | ﹤0.01% | 1818 |
|
|
2022
Q1 | $275K | Buy |
117,951
+13,416
| +13% | +$31.3K | ﹤0.01% | 2148 |
|
|
2021
Q4 | $486K | Buy |
104,535
+16,362
| +19% | +$76.1K | ﹤0.01% | 1518 |
|
|
2021
Q3 | $673K | Sell |
88,173
-10,163
| -10% | -$77.5K | 0.01% | 1357 |
|
|
2021
Q2 | $953K | Buy |
98,336
+15,247
| +18% | +$148K | 0.01% | 1182 |
|
|
2021
Q1 | $687K | Sell |
83,089
-19,280
| -19% | -$159K | 0.01% | 1342 |
|
|
2020
Q4 | $699K | Buy |
102,369
+8,421
| +9% | +$57.5K | 0.01% | 1302 |
|
|
2020
Q3 | $1.05M | Buy |
93,948
+14,675
| +19% | +$164K | 0.01% | 1009 |
|
|
2020
Q2 | $498K | Buy |
79,273
+15,945
| +25% | +$100K | 0.01% | 1382 |
|
|
2020
Q1 | $117K | Buy |
63,328
+25,448
| +67% | +$46.8K | ﹤0.01% | 1992 |
|
|
2019
Q4 | $128K | Sell |
37,880
-26,743
| -41% | -$90.4K | ﹤0.01% | 2202 |
|
|
2019
Q3 | $138K | Buy |
64,623
+5,820
| +10% | +$12.5K | ﹤0.01% | 2150 |
|
|
2019
Q2 | $157K | Buy |
58,803
+16,024
| +37% | +$42.8K | ﹤0.01% | 2167 |
|
|
2019
Q1 | $203K | Hold |
42,779
| – | – | ﹤0.01% | 1976 |
|
|
2018
Q4 | $103K | Hold |
42,779
| – | – | ﹤0.01% | 2290 |
|
|
2018
Q3 | $188K | Hold |
42,779
| – | – | ﹤0.01% | 2122 |
|
|
2018
Q2 | $308K | Buy |
+42,779
| New | +$308K | ﹤0.01% | 1708 |
|